| 2022-10-14 | Sale | Ultragenyx Pharmaceutical Inc. RARE | CFO & Executive Vice President | 1,629 0.0025% | $40.16 | $65,421 | +12.98% | |
| 2022-10-12 | Sale | Ultragenyx Pharmaceutical Inc. RARE | CFO & Executive Vice President | 3,484 0.0049% | $38.22 | $133,158 | +8.62% | |
| 2022-03-01 | Sale | Ultragenyx Pharmaceutical Inc. RARE | CFO & Executive Vice President | 420 0.0006% | $64.55 | $27,111 | -29.29% | |
| 2021-10-14 | Sale | Ultragenyx Pharmaceutical Inc. RARE | CFO & Executive Vice President | 3,261 0.0048% | $81.16 | $264,663 | -17.23% | |
| 2021-10-12 | Sale | Ultragenyx Pharmaceutical Inc. RARE | CFO & Executive Vice President | 3,477 0.0051% | $82.79 | $287,861 | -18.74% | |
| 2020-09-29 | Prelude Therapeutics Incorporated PRLD | director | 20,000 0.4125% | $19.00 | $380,000 | +34.76% |